PREVENT: Difference between revisions
Jump to navigation
Jump to search
Redirecting 'PREVENT' to 'Prospective Randomized Evaluation Of The Vascular Effects Of Norvasc Trial' |
Rim Halaby (talk | contribs) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{D-dimer}} | |||
{{CMG}} | |||
==Official Title== | |||
==Objective== | |||
==Sponsor== | |||
==Timeline== | |||
{| class="wikitable" border="1" style="background:WhiteSmoke" width="40%" | |||
|- | |||
| Colspan="2" style="background:Gainsboro" align="center"|'''Timeline''' | |||
|- | |||
| Style="width:30%"| '''Start Date'''||Style="width:70%"| | |||
|- | |||
| '''Run-In Period'''|| | |||
|- | |||
| '''End Date'''|| | |||
|- | |||
| '''Status'''|| | |||
|- | |||
|} | |||
<span style="font-size:85%">The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT00000614.</span> | |||
==Study Description== | |||
{| class="wikitable" border="1" style="background:WhiteSmoke" width="40%" | |||
|- | |||
| Colspan="2" style="background:Gainsboro" align="center"|'''Study Description''' | |||
|- | |||
| Style="width:30%"|'''Study Type'''|| Style="width:70%"| | |||
|- | |||
| '''Study Phase''' || | |||
|- | |||
| Colspan="2" style="background:Gainsboro" align="center"|'''Study Design''' | |||
|- | |||
| '''Allocation'''|| | |||
|- | |||
| '''Endpoint'''|| | |||
|- | |||
| '''Interventional Model'''|| | |||
|- | |||
| '''Masking'''|| | |||
|- | |||
| Colspan="2" style="background:Gainsboro" align="center"|'''Study Details''' | |||
|- | |||
| '''Primary Purpose'''|| | |||
|- | |||
| '''Condition'''|| | |||
|- | |||
| '''Intervention'''|| | |||
|- | |||
| '''Study Arms'''|| | |||
|- | |||
| '''Population Size'''|| | |||
|- | |||
|} | |||
<span style="font-size:85%">The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT00000614.</span> | |||
==Eligibility Criteria== | |||
===Inclusion Criteria=== | |||
===Exclusion Criteria=== | |||
==Outcomes== | |||
===Primary Outcomes=== | |||
===Secondary Outcomes=== | |||
==Publications== | |||
===Results=== | |||
===Conclusion=== | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Laboratory Test]] | |||
[[Category:Chemical pathology]] | |||
[[Category:Hematology]] | |||
[[Category:Fibrinolytic system]] | |||
[[Category:Cardiology]] | |||
[[Category:Pulmonology]] | |||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 21:31, 25 September 2013
|
D-Dimer Microchapters |
|
Clinical Correlation |
|---|
|
Clinical Trials |
|
PREVENT On the Web |
|
American Roentgen Ray Society Images of PREVENT |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Official Title
Objective
Sponsor
Timeline
| Timeline | |
| Start Date | |
| Run-In Period | |
| End Date | |
| Status | |
The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT00000614.
Study Description
| Study Description | |
| Study Type | |
| Study Phase | |
| Study Design | |
| Allocation | |
| Endpoint | |
| Interventional Model | |
| Masking | |
| Study Details | |
| Primary Purpose | |
| Condition | |
| Intervention | |
| Study Arms | |
| Population Size | |
The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT00000614.